Septerna Inc (NASDAQ: SEPN) is a Healthcare company (Biotechnology) with a market capitalization of $1.9B. The Maz Rating grades it against the other companies in its sector.
Septerna Inc's current Maz Rating and its five factor grades are for members: log in to see them.
At $39.68, Septerna Inc trades at 19.6x sales and 4.4x book value. Over the last twelve months it generated about $96M of revenue and a net loss of $61M. It runs a gross margin of 99.6%, an operating margin of -76.2% and a net margin of -61.3%. It shows return on equity of -15.0%, return on invested capital of -14.2% and a free cash flow yield of -4.1%. On the balance sheet: a debt-to-equity ratio of 0.05 and a current ratio of 4.84. Over the past 52 weeks the share price ranged from $21.31 to $53.34, with a beta of 2.20.
Septerna Inc does not currently pay a dividend.
10 Wall Street analyst ratings cover the stock: 1 Strong Buy and 9 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.